This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Polypharmacy, Safety, and Medication Adherence in Patients With Chronic Heart Failure With Reduced and Mildly Reduced Ejection Fraction | MicrobiomeTrials
← Back to trials NCT07640854
Polypharmacy, Safety, and Medication Adherence in Patients With Chronic Heart Failure With Reduced and Mildly Reduced Ejection Fraction Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-01-20Est. Completion: 2027-01
Enrollment target: 130 participantsLocations National Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russia Other microbiome trials you might be interested in Congestive Heart Failure(CHF)
By the re-analysis, in the BIOTOOL-CHF DISCO study, of a previously enrolled cohort of patients, a Biological Congestion…
Bologna, Italy Est. completion Sep 6, 2027
Heart Diseases Cardiovascular Diseases Heart Failure
Heart failure (HF) is a global, public health issue that affects more than 63 million people worldwide; this burden is e…
Aachen, Germany Est. completion Dec 31, 2026